BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guilherme VA, Ribeiro LNM, Alcântara ACS, Castro SR, Rodrigues da Silva GH, da Silva CG, Breitkreitz MC, Clemente-Napimoga J, Macedo CG, Abdalla HB, Bonfante R, Cereda CMS, de Paula E. Improved efficacy of naproxen-loaded NLC for temporomandibular joint administration. Sci Rep 2019;9:11160. [PMID: 31371737 DOI: 10.1038/s41598-019-47486-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Izza N, Watanabe N, Okamoto Y, Wibisono Y, Umakoshi H. Characterization of entrapment behavior of polyphenols in nanostructured lipid carriers and its effect on their antioxidative activity. J Biosci Bioeng 2022:S1389-1723(22)00162-1. [PMID: 35810136 DOI: 10.1016/j.jbiosc.2022.06.009] [Reference Citation Analysis]
2 Izza N, Watanabe N, Okamoto Y, Suga K, Wibisono Y, Kajimura N, Mitsuoka K, Umakoshi H. Dependence of the Core–Shell Structure on the Lipid Composition of Nanostructured Lipid Carriers: Implications for Drug Carrier Design. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c02214] [Reference Citation Analysis]
3 Babaie S, Taghvimi A, Hong JH, Hamishehkar H, An S, Kim KH. Recent advances in pain management based on nanoparticle technologies. J Nanobiotechnology 2022;20:290. [PMID: 35717383 DOI: 10.1186/s12951-022-01473-y] [Reference Citation Analysis]
4 Di Filippo LD, Lobato Duarte J, Hofstätter Azambuja J, Isler Mancuso R, Tavares Luiz M, Hugo Sousa Araújo V, Delbone Figueiredo I, Barretto-de-Souza L, Miguel Sábio R, Sasso-Cerri E, Martins Baviera A, Crestani CC, Teresinha Ollala Saad S, Chorilli M. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression. Int J Pharm 2022;618:121682. [PMID: 35307470 DOI: 10.1016/j.ijpharm.2022.121682] [Reference Citation Analysis]
5 Argueta-Figueroa L, Flores-Mejía LA, Ávila-Curiel BX, Flores-Ferreyra BI, Torres-Rosas R. Nonpharmacological Interventions for Pain in Patients with Temporomandibular Joint Disorders: A Systematic Review. Eur J Dent 2022. [PMID: 35259762 DOI: 10.1055/s-0041-1740220] [Reference Citation Analysis]
6 Bonetti FMR, de Paula E, Fonseca BB, da Silva GR, da Silva LSS, de Moura LD, Breitkreitz MC, Rodrigues da Silva GH, de Morais Ribeiro LN. Hybrid Nanobeads for Oral Indomethacin Delivery. Pharmaceutics 2022;14:583. [DOI: 10.3390/pharmaceutics14030583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lal A, Alam MK, Ahmed N, Maqsood A, Al-Qaisi RK, Shrivastava D, Alkhalaf ZA, Alanazi AM, Alshubrmi HR, Sghaireen MG, Srivastava KC. Nano Drug Delivery Platforms for Dental Application: Infection Control and TMJ Management-A Review. Polymers (Basel) 2021;13:4175. [PMID: 34883678 DOI: 10.3390/polym13234175] [Reference Citation Analysis]
8 Cao Y, Khan A, Ghorbani F, Mirzaei H, Singla P, Balakheyli H, Soltani A, Aghaei M, Azmoodeh Z, Aarabi M, Tavassoli S. Predicting adsorption behavior and anti-inflammatory activity of naproxen interacting with pure boron nitride and boron phosphide fullerene-like cages. Journal of Molecular Liquids 2021;339:116678. [DOI: 10.1016/j.molliq.2021.116678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
9 de Moura LD, Ribeiro LNM, de Carvalho FV, Rodrigues da Silva GH, Lima Fernandes PC, Brunetto SQ, Ramos CD, Velloso LA, de Araújo DR, de Paula E. Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma. Pharmaceutics 2021;13:1552. [PMID: 34683846 DOI: 10.3390/pharmaceutics13101552] [Reference Citation Analysis]
10 Jounaki K, Makhmalzadeh BS, Feghhi M, Heidarian A. Topical ocular delivery of vancomycin loaded cationic lipid nanocarriers as a promising and non-invasive alternative approach to intravitreal injection for enhanced bacterial endophthalmitis management. Eur J Pharm Sci 2021;167:105991. [PMID: 34517103 DOI: 10.1016/j.ejps.2021.105991] [Reference Citation Analysis]
11 Kalave S, Chatterjee B, Shah P, Misra A. Transdermal Delivery of Macromolecules Using Nano Lipid Carriers. Curr Pharm Des 2021;27:4330-40. [PMID: 34414868 DOI: 10.2174/1381612827666210820095330] [Reference Citation Analysis]
12 Barry F, Chai F, Chijcheapaza-Flores H, Garcia-Fernandez MJ, Blanchemain N, Nicot R. Systematic review of studies on drug-delivery systems for management of temporomandibular-joint osteoarthritis. J Stomatol Oral Maxillofac Surg 2021:S2468-7855(21)00163-4. [PMID: 34400376 DOI: 10.1016/j.jormas.2021.08.003] [Reference Citation Analysis]
13 Pinto CM, Horta LS, Soares AP, Carvalho BA, Ferreira E, Lages EB, Ferreira LAM, Faraco AAG, Santiago HC, Goulart GAC. Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice. Pharmaceutics 2021;13:1021. [PMID: 34371713 DOI: 10.3390/pharmaceutics13071021] [Reference Citation Analysis]
14 Noreen S, Pervaiz F, Ashames A, Buabeid M, Fahelelbom K, Shoukat H, Maqbool I, Murtaza G. Optimization of Novel Naproxen-Loaded Chitosan/Carrageenan Nanocarrier-Based Gel for Topical Delivery: Ex Vivo, Histopathological, and In Vivo Evaluation. Pharmaceuticals (Basel) 2021;14:557. [PMID: 34207951 DOI: 10.3390/ph14060557] [Reference Citation Analysis]
15 Rapalli VK, Sharma S, Roy A, Alexander A, Singhvi G. Solid lipid nanocarriers embedded hydrogel for topical delivery of apremilast: In-vitro, ex-vivo, dermatopharmacokinetic and anti-psoriatic evaluation. Journal of Drug Delivery Science and Technology 2021;63:102442. [DOI: 10.1016/j.jddst.2021.102442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tavares Luiz M, Santos Rosa Viegas J, Palma Abriata J, Viegas F, Testa Moura de Carvalho Vicentini F, Lopes Badra Bentley MV, Chorilli M, Maldonado Marchetti J, Tapia-Blácido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. Eur J Pharm Biopharm 2021;165:127-48. [PMID: 33992754 DOI: 10.1016/j.ejpb.2021.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Rodrigues da Silva GH, Lemes JBP, Geronimo G, Freitas de Lima F, de Moura LD, Carvalho Dos Santos A, Carvalho NS, Malange KF, Breitkreitz MC, Parada CA, de Paula E. Lipid nanoparticles loaded with butamben and designed to improve anesthesia at inflamed tissues. Biomater Sci 2021;9:3378-89. [PMID: 33949447 DOI: 10.1039/d1bm00077b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mittal D, Biswas L, Verma AK. Redox resetting of cisplatin-resistant ovarian cancer cells by cisplatin-encapsulated nanostructured lipid carriers. Nanomedicine (Lond) 2021;16:979-95. [PMID: 33970681 DOI: 10.2217/nnm-2020-0400] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ahamad N, Kar A, Mehta S, Dewani M, Ravichandran V, Bhardwaj P, Sharma S, Banerjee R. Immunomodulatory nanosystems for treating inflammatory diseases. Biomaterials 2021;274:120875. [PMID: 34010755 DOI: 10.1016/j.biomaterials.2021.120875] [Reference Citation Analysis]
20 El-Laithy HM, Youssef A, El-Husseney SS, El Sayed NS, Maher A. Enhanced alveo pulmonary deposition of nebulized ciclesonide for attenuating airways inflammations: a strategy to overcome metered dose inhaler drawbacks. Drug Deliv 2021;28:826-43. [PMID: 33928836 DOI: 10.1080/10717544.2021.1905747] [Reference Citation Analysis]
21 Izza N, Suga K, Okamoto Y, Watanabe N, Bui TT, Wibisono Y, Fadila CR, Umakoshi H. Systematic Characterization of Nanostructured Lipid Carriers from Cetyl Palmitate/Caprylic Triglyceride/Tween 80 Mixtures in an Aqueous Environment. Langmuir 2021;37:4284-93. [PMID: 33797256 DOI: 10.1021/acs.langmuir.1c00270] [Reference Citation Analysis]
22 Wu M, Cai J, Yu Y, Hu S, Wang Y, Wu M. Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective. Front Pharmacol 2020;11:596099. [PMID: 33584275 DOI: 10.3389/fphar.2020.596099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Placha D, Jampilek J. Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems. Pharmaceutics 2021;13:64. [PMID: 33419176 DOI: 10.3390/pharmaceutics13010064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
24 Tartaglia GM, Gizdulich A, Farronato M, Gupta RJ, Connelly ST. Electroporation technique for joint pain - Pilot feasibility study on TMD patients. Clin Exp Dent Res 2020;6:642-9. [PMID: 33280278 DOI: 10.1002/cre2.327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Rapalli VK, Kaul V, Waghule T, Gorantla S, Sharma S, Roy A, Dubey SK, Singhvi G. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. European Journal of Pharmaceutical Sciences 2020;152:105438. [DOI: 10.1016/j.ejps.2020.105438] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 16.0] [Reference Citation Analysis]
26 Dong Z, Iqbal S, Zhao Z. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects. AAPS PharmSciTech 2020;21:64. [PMID: 31932990 DOI: 10.1208/s12249-019-1597-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]